Radiomic tumor phenotypes augment molecular profiling in predicting recurrence free survival after breast neoadjuvant chemotherapy

BACKGROUND: Early changes in breast intratumor heterogeneity during neoadjuvant chemotherapy may reflect the tumor’s ability to adapt and evade treatment. We investigated the combination of precision medicine predictors of genomic and MRI data towards improved prediction of recurrence free survival...

Descripción completa

Detalles Bibliográficos
Autores principales: Chitalia, Rhea, Miliotis, Marios, Jahani, Nariman, Tastsoglou, Spyros, McDonald, Elizabeth S., Belenky, Vivian, Cohen, Eric A., Newitt, David, van’t Veer, Laura J., Esserman, Laura, Hylton, Nola, DeMichele, Angela, Hatzigeorgiou, Artemis, Kontos, Despina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10063641/
https://www.ncbi.nlm.nih.gov/pubmed/36997615
http://dx.doi.org/10.1038/s43856-023-00273-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10063641/
https://www.ncbi.nlm.nih.gov/pubmed/36997615
http://dx.doi.org/10.1038/s43856-023-00273-1

Ejemplares similares